PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Methotrexate (Mexate)

Subscribe to Selected New Research on Methotrexate

12403 relevant articles (1186 outcomes, 1796 trials/studies) found for this Drug

Description: An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.

Also Known As:

Mexate; Methotrexate Hydrate; Methotrexate, (D)-Isomer; Methotrexate, (DL)-Isomer; Methotrexate, Dicesium Salt; Methotrexate, Disodium Salt; Methotrexate, Sodium Salt; Dicesium Salt Methotrexate; Disodium Salt Methotrexate; Hydrate, Methotrexate; Sodium Salt Methotrexate; Amethopterin; L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-

Relationship Network

Drug Context: Research Results

-

Heterocyclic Compounds: 25

-

2-Ring Heterocyclic Compounds

-

-

-

Aminopterin: 225

-

Methotrexate: 12403

*

CMF regimen: 779

*

*

CARE protocol: 64

*

MFL protocol: 63

*

CMFVP protocol: 39

*

PROMACE-CytaBOM protocol: 34

*

CMFP protocol: 31

*

7-hydroxymethotrexate: 30

*

LSA2-L2 protocol: 30

*

methotrexate polyglutamate: 27

*

VMBP protocol: 25

*

M-VAC regimen: 23

*

MACOP-B regimen: 12

*

methotrexate-serum albumin: 11

*

CMF protocol: 9

*

N-(1-((2,4-diamino-6-pteridinyl)methyl)-3,4-dihydro -2H-1,4-benzothiazine-7-carbonyl)-L-2-aminoadipic acid: 9

*

AMF protocol: 8

*

fluoresceinated methotrexate: 8

*

*

hexa CAF protocol: 6

*

ANAVACYM protocol: 5

*

BFM 78 protocol: 5

*

CMFPT protocol: 5

*

COMF protocol: 5

*

M-VAC protocol: 5

*

MACHO protocol: 5

*

*

LMB89 protocol: 4

*

MAC combination: 4

*

MACOP-B protocol: 4

*

methotrexate-alpha-phenylalanine: 4

*

3',5'-dichloromethotrexate: 3

*

methotrexate-gamma-1,2-dimyristoylphosphatidylethanolamine: 3

*

*

CMF-B protocol: 2

*

*

COMP protocol: 2

*

DTPA-methotrexate: 2

*

EMA-CO protocol: 2

*

M-BACOD protocol: 2

*

*

methotrexate-gamma-aspartate: 2

*

MMM protocol 2: 2

*

tetrahydromethotrexate: 2

*

VBM protocol: 2

*

5-deazamethotrexate: 1

*

AIEOP acute lymphoblastic leukemia protocol: 1

*

BCMV protocol: 1

*

biotin-SS-methotrexate: 1

*

BMFt protocol: 1

*

BOMES protocol: 1

*

BOP-CISCA-POMB-ACE regimen: 1

*

C'MP protocol: 1

*

CAM combination: 1

*

CAMBO-VIP protocol: 1

*

CAMP protocol: 1

*

CCG-141 protocol: 1

*

CMED protocol: 1

*

CNR-NEO 2 protocol: 1

*

COMPA regimen: 1

*

COSS-86 protocol: 1

*

EMB protocol: 1

*

FEMTX-P protocol: 1

*

gamma-tert-butyl methotrexate: 1

*

L-6 protocol: 1

*

LNH87-2 protocol: 1

*

M-VEC protocol: 1

*

MATILDE regimen: 1

*

MCNO regimen: 1

*

MDC protocol: 1

*

MEC protocol 1: 1

*

methotrexate bisphosphonate: 1

*

N,N,O,O-tetrakis(tert-butyldimethylsilyl)methotrexate: 1

*

New York protocol: 1

*

*

OS 87 protocol: 1

*

PBMF protocol: 1

*

ProMACE-MOPP protocol: 1

*

protocol 8001: 1

*

SIOP-II protocol: 1

*

Stanford University protocol: 1

*

T-6 protocol: 1

*

T-8801 protocol: 1

*

VIM-Bleo protocol: 1

*

VMP protocol: 1

*

(COMPADRI)-III protocol

*

(N-(4-amino-4-deoxy-N(10)-methylpteroyl)amino)-3-chloro-4,5-dihydro-5-isoxazoleacetic acid

*

06-Paris-LA-66 protocol

*

10-ethylaminopterin

*

3',5'-difluoromethotrexate

*

3'-chloromethotrexate

*

*

4-(N-((2,4-diamino-6-pteridinyl)methyl)amino)benzoic acid

*

4-amino-10-methylpteroylhexa-gamma-glutamic acid

*

5-hexadecyl methotrexate

*

5-monobutyl methotrexate

*

7-hydroxydichloromethotrexate

*

A-VBM-FH6 protocol

*

*